In vivo sodium iodide symporter gene therapy of prostate cancer

Gene Therapy

Volumn 8, Issue 20, 2001, Pages 1524-1531

  Spitzweg, C ^a   Dietz, A B ^b   O'Connor, M K ^a   Bergert, E R ^a   Tindall, D J ^a   Young, C Y F ^a   Morris, J C ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Adenovirus; Gene therapy; Prostate cancer; Radioiodine therapy; Sodium iodide symporter

Indexed keywords

IODINE 131; SODIUM CHLORIDE; SODIUM IODIDE SYMPORTER; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CANCER THERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG ACCUMULATION; DRUG EFFICACY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; INJECTION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; THYROID CANCER; THYROID GLAND; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 0035171630     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301558     Document Type: Article

References (32)

1. Cloning and characterization of the thyroid iodide transporter
2. Cloning of the human sodium iodide symporter
3. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter
4. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extra-thyroid pathophysiology
5. Thyroid iodine transport
6. Carcinoma of follicular epithelium: Radioiodine and other treatments and outcomes
7. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery
8. - Symporter gene
9. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene
10. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy
11. Prostate cancer: Therapeutics, diagnostics, and basic studies
12. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines
13. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter
14. Monoclonal antibodies against the human sodium iodide symporter: Utility for immunocytochemistry of thyroid cancer
15. Iodide transport in the thyroid gland
16. Cancer statistics
17. Gene therapy for prostate cancer
18. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans
19. Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen
20. Tissue specific promoters in targeting systemically delivered gene therapy
21. Gene therapy for prostate cancer
22. Development and application of adenoviral vectors for gene therapy of cancer
23. In situ gene therapy for prostate cancer
24. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells
25. The function of various types of thyroid carcinoma as revealed by the radioautographic demonstration of radioactive iodine
26. Metastatic thyroid carcinoma in man concentrating iodide without organification
27. - Symporters for radioiodide concentrator gene therapy
28. Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism
29. Iodine transport in a continous line of cultured cells from rat thyroid
30. Growth of an androgen-sensitive human prostate cancer cell line, LNCaP, in nude mice
31. - Symport activity is present in membrane vesicles from thyrotropin-deprived non-I-transporting cultured thyroid cells
32. Acceleration of human prostate cancer in vivo by factors produced by prostate and bone fibroblasts